The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment

Flavia Kheiraoui; Chiara De Waure; Maria Lucia Specchia; Maria Luisa Di Pietro; L Mantovani; Silvio Capizzi; Chiara Cadeddu; Francesco Di Nardo; Anna Maria Ferriero; Maria Assunta Veneziano; G Furneri; Maria Rosaria Gualano; Nicola Nicolotti; Antonella Sferrazza; Pietro Refolo; Maria Daniela Gliubizzi; R Saulle; Giuseppe La Torre; Walter Ricciardi

doi:10.1093/eurpub/ckt124.117

The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment

Flavia Kheiraoui
, Chiara De Waure
, Maria Lucia Specchia
, Maria Luisa Di Pietro
, L Mantovani
, Silvio Capizzi
, Chiara Cadeddu
, Francesco Di Nardo
, Anna Maria Ferriero
, Maria Assunta Veneziano
, G Furneri
, Maria Rosaria Gualano
, Nicola Nicolotti
, Antonella Sferrazza
, Pietro Refolo
, Maria Daniela Gliubizzi
, R Saulle
, Giuseppe La Torre
, Walter Ricciardi

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Streptococcus pneumoniae (Spn) is a common cause of Community-Acquired Pneumonia (CAP) and Invasive Pneunmococcal Diseases (IPD). Risk for infection increases in particular in elderly. The aim of the study was to evaluate the introduction of 13-valent conjugate pneumococcal vaccine (PCV13) among patients ≥50 years.

Lingua originale	Inglese
pagine (da-a)	284-285
Numero di pagine	2
Rivista	European Journal of Public Health
DOI	https://doi.org/10.1093/eurpub/ckt124.117
Stato di pubblicazione	Pubblicato - 2013

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

health technology assessment

Accesso al documento

10.1093/eurpub/ckt124.117

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Kheiraoui, F., De Waure, C., Specchia, M. L., Di Pietro, M. L., Mantovani, L., Capizzi, S., Cadeddu, C., Di Nardo, F., Ferriero, A. M., Veneziano, M. A., Furneri, G., Gualano, M. R., Nicolotti, N., Sferrazza, A., Refolo, P., Gliubizzi, M. D., Saulle, R., La Torre, G., & Ricciardi, W. (2013). The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment. European Journal of Public Health, 284-285. https://doi.org/10.1093/eurpub/ckt124.117

@article{ce485d705d944e65bd034670a292c363,

title = "The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment",

abstract = "Streptococcus pneumoniae (Spn) is a common cause of Community-Acquired Pneumonia (CAP) and Invasive Pneunmococcal Diseases (IPD). Risk for infection increases in particular in elderly. The aim of the study was to evaluate the introduction of 13-valent conjugate pneumococcal vaccine (PCV13) among patients ≥50 years.",

keywords = "health technology assessment, health technology assessment",

author = "Flavia Kheiraoui and \{De Waure\}, Chiara and Specchia, \{Maria Lucia\} and \{Di Pietro\}, \{Maria Luisa\} and L Mantovani and Silvio Capizzi and Chiara Cadeddu and \{Di Nardo\}, Francesco and Ferriero, \{Anna Maria\} and Veneziano, \{Maria Assunta\} and G Furneri and Gualano, \{Maria Rosaria\} and Nicola Nicolotti and Antonella Sferrazza and Pietro Refolo and Gliubizzi, \{Maria Daniela\} and R Saulle and \{La Torre\}, Giuseppe and Walter Ricciardi",

year = "2013",

doi = "10.1093/eurpub/ckt124.117",

language = "English",

pages = "284--285",

journal = "European Journal of Public Health",

issn = "1101-1262",

publisher = "Oxford University Press",

}

Kheiraoui, F, De Waure, C, Specchia, ML , Di Pietro, ML, Mantovani, L, Capizzi, S, Cadeddu, C, Di Nardo, F, Ferriero, AM, Veneziano, MA, Furneri, G, Gualano, MR, Nicolotti, N, Sferrazza, A, Refolo, P, Gliubizzi, MD, Saulle, R, La Torre, G & Ricciardi, W 2013, 'The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment', European Journal of Public Health, pagg. 284-285. https://doi.org/10.1093/eurpub/ckt124.117

TY - JOUR

T1 - The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment

AU - Kheiraoui, Flavia

AU - De Waure, Chiara

AU - Specchia, Maria Lucia

AU - Di Pietro, Maria Luisa

AU - Mantovani, L

AU - Capizzi, Silvio

AU - Cadeddu, Chiara

AU - Di Nardo, Francesco

AU - Ferriero, Anna Maria

AU - Veneziano, Maria Assunta

AU - Furneri, G

AU - Gualano, Maria Rosaria

AU - Nicolotti, Nicola

AU - Sferrazza, Antonella

AU - Refolo, Pietro

AU - Gliubizzi, Maria Daniela

AU - Saulle, R

AU - La Torre, Giuseppe

AU - Ricciardi, Walter

PY - 2013

Y1 - 2013

N2 - Streptococcus pneumoniae (Spn) is a common cause of Community-Acquired Pneumonia (CAP) and Invasive Pneunmococcal Diseases (IPD). Risk for infection increases in particular in elderly. The aim of the study was to evaluate the introduction of 13-valent conjugate pneumococcal vaccine (PCV13) among patients ≥50 years.

AB - Streptococcus pneumoniae (Spn) is a common cause of Community-Acquired Pneumonia (CAP) and Invasive Pneunmococcal Diseases (IPD). Risk for infection increases in particular in elderly. The aim of the study was to evaluate the introduction of 13-valent conjugate pneumococcal vaccine (PCV13) among patients ≥50 years.

KW - health technology assessment

UR - http://hdl.handle.net/10807/59716

U2 - 10.1093/eurpub/ckt124.117

DO - 10.1093/eurpub/ckt124.117

M3 - Article

SN - 1101-1262

SP - 284

EP - 285

JO - European Journal of Public Health

JF - European Journal of Public Health

ER -

The 13-valent pneumococcal conjugated vaccine introduction in subjects aged> 50 years: the result of a Health Technology Assessment

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo